Leukocyte-polytetrafluoroethylene interaction enhances proliferation of vascular smooth muscle cells via tumor necrosis factor-α secretion

Kidney International

Volumn 52, Issue 6, 1997, Pages 1478-1485

  Mattana, Joseph ^a   Effiong, Charles ^a   Kapasi, Aditi ^a   Singhal, Pravin C ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Hemodialysis; Leukocytes; Polytetrafluoroethylene; Smooth muscle cells; Tumor necrosis factor

Indexed keywords

POLITEF; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL PROLIFERATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODIALYSIS; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; LEUKOCYTE; LIGAND BINDING; MONONUCLEAR CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; THROMBOSIS; VASCULAR ACCESS; VASCULAR SMOOTH MUSCLE; VEIN ANASTOMOSIS;

EID: 0031463558     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.478     Document Type: Article

References (27)

1. FELDMAN HI, HELD PJ, HUTCHINSON JT, STOIBER E, HARTIGAN MF, BERLIN JA: Hemodialysis vascular access morbidity in the United States. Kidney Int 43:1091-1096, 1993
2. CHAZAN JA, LONDON MR, PONO LM: Long-term survival of vascular access in a large chronic hemodialysis population. Nephron 69:228-233, 1995
3. FAN PY, SCHWAB SJ: Vascular access: Concepts for the 1990s. J Am Soc Nephrol 3:1-11, 1992
4. HIRTH RA, TURENNE MN, WOODS JD, YOUNG EW, PORT FK, PAULY MV, HELD PJ: Predictors of type of vascular access in hemodialysis patients. JAMA 276:1303-1308, 1996
5. SUKHATME VP: Vascular access stenosis: Prospects for prevention and therapy. Kidney Int 49:1161-1174, 1996
6. MUNDA R, FIRST MR, ALEXANDER JW, LINNEMANN CC JR, FIDLER JP, KITTUR D: Polytetrafluoroethylene graft survival in hemodialysis. JAMA 249:219-222, 1983
7. JENKINS AM, BUIST TAS, GLOVER SD: Medium-term followup of forty autogenous vein and forty polytetrafluoroethylene (Gore-Tex) grafts for vascular access. Surgery 88:667-672, 1980
8. CULP K, FLANIGAN M, TAYLOR L, ROTHSTEIN M: Vascular access thrombosis in new hemodialysis patients. Am J Kidney Dis 26:341-346, 1995
9. GOLDWASSER P, AVRAM MM, COLLIER JT, MICHEL M-A, GUSIK S-A, MITTMAN N: Correlates of vascular access occlusion in hemodialysis. Am J Kidney Dis 24:785-794, 1994
10. DE MARCHI S, FALLETI E, GIACOMELLO R, STEL G, CECCHIN E, SEPIACCI G, BORTOLOTTI N, ZANELLO F, GONANO F, BARTOLI E: Risk factors for vascular disease and artcriovcnous fistula dysfunction in hemodialysis patients. J Am Soc Nephrol 7:1169-1177, 1996
11. PRAKASH R, MILLER CC, SUKI WN: Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am J Kidney Dis 26:347-352, 1995
12. SWEDBERG SH, BROWN BG, SIGLEY R, WIGHT TN, GORDON D, NICHOLLS SC: Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Circulation 80:1726-1736, 1989
13. TANAKA H, SUKHOVA G, SCHWARTZ D, LIBBY P: Proliferating arterial smooth muscle cells after balloon injury express TNF-α hut not interleukin-1 or or basic fibroblast growth factor. Arterioscler Thromb Vasc Biol 16:12-18, 1996
14. TANAKA H, SWANSON SJ, SUKHOVA G, SCHOEN FJ, LIBBY P: Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-α and proliferate during acute rejection of rabbit cardiac allografts. Am J Pathol 147:617-626, 1995
15. FARIES PL, MARIN ML, VEITH FJ, RAMIREZ JA, SUGGS WD, PARSONS RE, SANCHEZ L, LYON RT: Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model. J Vasc Surg 24:463-471, 1996
16. KALMAN PG, ROTSTEIN OD, NIVEN J, GLYNN MFX, ROMASCHIN AD: Differential stimulation of macrophage procoagulant activity by vascular grafts. J Vasc Surg 17:531-537, 1993
17. BENTON LD, PUROHIT U, KHAN M, GRECO RS: The biologic role of β, integrins in the host response to expanded polytetrafluoroethylene. J Surg Res 64:116-119, 1996
18. KATZ DA, HAIMOVICH B, GRECO RS: Neutrophil activation by expanded polytetrafluoroethylene is dependent on the induction of protein phosphorylation. Surgery 116:446-454, 1994
19. MILLER KM, ANDERSON JM: In vitro stimulation of fibroblast activity by factors generated from human monocytes activated by biomedical polymers. J Biomed Mater Res 23:911-930, 1989
20. MULLER WA, WEIGL SA: Monocyte-selective transendothelial migration: Dissection of the binding and transmigration phases by an in vitro assay. J Exp Med 176:819-828, 1992
21. RE F, ZANETTI A, SIRONI M, POLENTARUTTI N, LANFRANCONE L, DEJANA E, COLOTTA F: Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 127:537-546, 1994
22. MATTANA J, MARGILOFF L, SINGHAL PC: Oxidation of mesangial matrix using a mixed function oxidase system augments adhesion of macrophages: Possible role of macrophage scavenger receptors. Biochem Biophys Res Commun 212:63-69, 1995
23. WINDUS DW: The effect of comorbid conditions on hemodialysis access patency. Adv Ren Replace Ther 1:148-154, 1994
24. MUNRO E, CHAN P, PATEL M, BETTERIDGE L, GALLAGHER K, SCHACHTER M, SEVER P, WOLFE J: Consistent responses of the human vascular smooth muscle cell in culture: Implications for restenosis. J Vasc Surg 20:482-487, 1994
25. FRASER I, HUGHES D, GORDON S: Divalent cation-independent macrophage adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature 364:343-346, 1993
26. DACKIW AP, NATHENS AB, MARSHALI JC, ROTSTEIN OD: Integrin engagement induces monocyte procoagulant activity and tumor necrosis factor production via induction of tyrosine phosphorylation. J Surg Res 64:210-215, 1996
27. YUN JK, DEFIFE K, COLTON E, STACK S, AZEEZ A, CAHALAN L, VERHOEVEN M, CAHALAN P, ANDERSON JM: Human monocyte/ macrophage adhesion and cytokine production on surface-modified poly(tetrafluoroethylene/hexafluoroprolylene) polymers with and without protein preadsorption. J Biomed Mater Res 29:257-268, 1995